Do You Know Your NOACs? Let’s Review the Novel Oral Anticoagulants
Learn about the new oral anticoagulants (NOACs) like apixaban, dabigatran, edoxaban, and rivaroxaban. Understand their mechanisms, uses, and differences compared to warfarin for better patient care.
About this course
When it comes to oral anticoagulants, warfarin is no longer the only game in town. The past decade has brought new oral anticoagulant therapy with novel mechanisms of action. Whether practicing in a health system or community setting, understanding the uses, new mechanisms of action, and differences between these new agents is crucial to exceptional patient care. This activity will review the four novel oral anticoagulants (NOACs): apixaban, dabigatran, edoxaban, and rivaroxaban, and will discuss their mechanism of action, indications, dosing, adverse effects and drug interactions. The activity will include a review of the anticoagulation cascade with a focus on the place of each drug in the cascade and how they differ from warfarin. Other discussions will include the role of NOACs in the treatment of atrial fibrillation and prevention of deep vein thrombosis and pulmonary embolism based on current CHEST guidelines as well as those developed by the American College of Cardiology, American Heart Association, and European Society of Cardiology. Lastly, the activity will present various counseling points, precautions, and boxed warnings pertinent to patient care.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Faculty
InstructorsYou might also be interested in
What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Requirements
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
- Windows 8.1
- Windows 10
- Mac OS X 10.1+
- iOS 10+
- Android 4.3+
- Google Chrome
- Microsft Edge
- Mozilla Firefox
- Adobe Acrobat Reader
- Broadband Internet Connection: T1
- Hi-speed DSL or Cable4G cellular connection